KG Capital Management

Position in NVS — Novartis AG

CIK 1771687 ST. FRANCISVILLE, LA

Position in NVS

as of Jun 30, 2026 · filed Aug 7, 2026 Compact

Position Value

$320,649

New position

Shares Held

2,046

first reported quarter

Ownership

0.000%

of shares outstanding

% of Portfolio

0.27%

of 13F equity value

Holder Rank

#1,095

of 1,603 holders

Holding Since

Jun 2026

1 quarter on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

KG Capital Management holds $5,166,010 across 6 Drug Manufacturers - General names. NVS ranks #5 (6.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	JNJ	Johnson & Johnson	8,256	$2,096,776
2	LLY	ELI LILLY & Co	1,195	$1,433,318
3	AMGN	Amgen Inc	1,533	$555,129
4	GSK	GSK plc	10,568	$553,974
5	NVS	Novartis AG This page	2,046	$320,649
6	BMY	Bristol Myers Squibb Co	3,578	$206,164

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$320,649	2,046	—	Shares	Sole	2026-08-07
No filing history on record for this holder in this stock.